Summary
GBI Research, the
leading business intelligence provider, has released its latest research,
'Non-Hodgkin Lymphoma Therapeutics in Asia-Pacific Markets to 2020 - Novel
Technologies Show Considerable Promise in Relapsed/Refractory Setting', which
provides in-depth insights into the indication. It gives an estimation of
market size for 2013 along with forecasts until 2020 for the Asia-Pacific
(APAC) region, which comprises Australia, China, India and Japan.
It also covers disease
epidemiology, treatment algorithms, treatment patterns, in-depth analysis of
clinical trials including failure rates and pipeline analysis, and analysis of
deals relevant to Non-Hodgkin Lymphoma (NHL).
To Get More Details @ http://www.radiantinsights.com/research/non-hodgkin-lymphoma-therapeutics-in-asia-pacific-markets-to-2020-novel-technologies-show-considerable-promise-in-relapsed-refractory-setting
The market in the APAC
region was worth an estimated $1.1 billion in 2013 and is expected to grow at a
Compound Annual Growth Rate (CAGR) of 6.6% to $1.7 billion in 2020. The
expected launches of promising drugs, including novel protein kinase inhibitors
and next-generation monoclonal antibodies, as well as the continued use of the
current blockbuster, Rituxan/Mabthera, will be the key growth drivers. The
launch of premium-priced novel glycol-engineered antibody; obinutuzumab; kinase
inhibitors including idelalisib and ibrutinib; and the mTOR inhibitor
everolimus are also expected to have a significant impact, as is the
anticipated approval of immunomodulatory agent Revlimid as a maintenance
setting.
An increasingly aging
population and a year-on-year increase in the number of incident cases will
provide an additional boost. However, the recent implementation of a price
ceiling on essential drugs in India; anticipated pricing restrictions in China;
and low access, penetration and price erosion due to generic dominance,
especially in India, stand to curtail the APAC NHL market.
About Radiant Insights
Radiant Insights is a platform for companies looking to meet
their market research and business intelligence requirements. We assist and
facilitate organizations and individuals procure market research reports,
helping them in the decision making process. We have a comprehensive collection
of reports, covering over 40 key industries and a host of micro markets. In
addition to over extensive database of reports, our experienced research
coordinators also offer a host of ancillary services such as, research
partnerships/ tie-ups and customized research solutions.
For More Information Visit – Radiant Insights
Contact:
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@radiantinsights.com
No comments:
Post a Comment